CHICAGO--(BUSINESS WIRE)--Igenbio, Inc., a genomics and informatics solutions provider, has expanded its service offerings into the human genome analytics market. With its flagship cloud-based Software as a Service (SaaS) analytics platform ERGO, known in the microbial and synthetic biology spaces, Igenbio, Inc. now offers human genome RNA sequence analytics. ERGO provides fully featured coding and non-coding gene expression analytics for RNA-Seq. ERGO’s human analytics module is easy to use and surpasses present desktop software offerings for computing differential gene expression, clustering, and variant detection. “ERGO frees scientists from the costly hassle of complex data and software management,” said Vinayak Kapatral Ph.D. President, CEO of Igenbio, Inc.
